What is LOPJLB’s current signal on LTGO?

LOPJLB’s latest quantitative signal on Latigo Biotherapeutics Inc. (LTGO) is SELL. Signals are updated daily.

What market regime is LTGO in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Latigo Biotherapeutics Inc. (LTGO) do?

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquarte…

Where is Latigo Biotherapeutics Inc. based / listed?

Latigo Biotherapeutics Inc. is based in US, listed on NASDAQ.

Latigo Biotherapeutics Inc. (LTGO)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$16.26-2.22%Close

SELL

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $978M
Beta: 0.00
Short % float: 2.91%

Days to cover: 2.1
SI change: +45.8%

1W: -10.17%
1M: -29.43%

vs SPY 1W: -12.11%
vs SPY 1M: -30.83%

Industry peers

FMP comparable companies · ranked by market cap

PCRXSELLPacira BioSciences, Inc.$974MRECOVERYQ 7$24.76-1.16%
COLLSELLCollegium Pharmaceutical, Inc.$710MBEARQ 14$21.88+0.05%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news